Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trialHarold Atkins, Mark S. Freedman, Isabelle Bence‐Bruckler et al.|The Lancet|2016Cited by 327
Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell TransplantationAdam Bryant, Christopher Bredeson, Harold Atkins et al.|JAMA Neurology|2016Cited by 103
Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell TransplantationAdam Bryant, Natasha Kekre, Ranjeeta Mallick et al.|Transplantation and Cellular Therapy|2017Cited by 36